Aspen Aerogels logo

Aspen Aerogels (ASPN) Q4 2024 Annual Earnings

ASPN·Reported February 12, 2025·After market close

Aspen Aerogels reported Q4 2024 revenue of $123.1M, beat analyst consensus of $120.8M by $2.3M. Diluted EPS came in at $0.15, beat the $0.04 consensus by $0.11.

Revenue
$123.1Mbeat by $2.3M
Consensus: $120.8M
Diluted EPS
$0.15beat by $0.11
Consensus: $0.04
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q4 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Aspen Aerogels's Q4 2024 earnings report.

Aspen Aerogels (ASPN) reported Q4 2024 earnings on February 12, 2025 after market close.

Aspen Aerogels reported revenue of $123.1M and diluted EPS of $0.15 for Q4 2024.

Revenue beat the consensus estimate of $120.8M by $2.3M. EPS beat the consensus estimate of $0.04 by $0.11.

You can read the 10-K periodic report (0000950170-25-029252) directly on SEC EDGAR. The filing index links above go to sec.gov.